Abbott
17 articles related to "Abbott"
-
Brazilians demand greater access to crucial HIV drug
Civil society files patent opposition to increase access to HIV/AIDS medicines Rio de Janeiro, 10 November 2011 – Brazilian civil society will oppose a patent application today for the key...
Press Release – Last updated 11 November 2011
www.msfaccess.org/about-us/media-room/press-releases/brazilians-demand-greater-access-crucial-hiv-drug -
India Rejects Patents for Two Key AIDS Drugs
New Delhi, 7 January 2011 - The Indian Patent Office has just rejected patent applications related to two AIDS medicines – lopinavir/ritonavir and atazanavir - on the basis that they did not merit...
Press Release – Last updated 12 July 2011
www.msfaccess.org/about-us/media-room/press-releases/india-rejects-patents-two-key-aids-drugs -
Heat-stable ritonavir approved
Heat-stable ritonavir approved: Years of medical double standards and stranglehold by Abbott come to an end 12 February 2010 -- Both the European Medicines Agency (EMEA) and the U.S. Food and Drug...
Statements, Speeches, Letters – Last updated 12 February 2010
www.msfaccess.org/content/heat-stable-ritonavir-approved -
Untangling the Web Update to 10th edition
Highlights: · Abbott’s new release of pediatric LPV/r 100/25mg tablet (heatstable) is half the price of the adult tablet. · Gilead offered TDF single and combination...
Report – Last updated 21 February 2008
www.msfaccess.org/content/untangling-web-update-10th-edition -
Letter to Abbott. Access to Kaletra in China
Mr. Robert Dintruff Director, Global Care Initiatives Geneva, July 13 2005 Dear Mr. Dintruff, MSF began antiretroviral treatment in 2001 and is now treating more than 34,000 patients in...
Statements, Speeches, Letters – Last updated 11 November 2005
www.msfaccess.org/content/letter-abbott-access-kaletra-china -
Abbott's new and improved Kaletra: Only in the US... But what about the rest of the world?
Médecins Sans Frontières (MSF) is deeply concerned that Abbott’s new version of the secondline fixed dose combination lopinavir/ritonavir – LPV/r, marketed as Kaletra, is not...
Briefing – Last updated 07 February 2006
www.msfaccess.org/content/abbotts-new-and-improved-kaletra-only-us-what-about-rest-world -
Sign-on letter to Abbott
April 5, 2006 Miles White Chairman and CEO Abbott Laboratories 100 Abbott Park Road Abbott Park, IL 60064 Dear Mr. White, We are writing to you to express our concern about the...
Statements, Speeches, Letters – Last updated 15 March 2006
www.msfaccess.org/content/sign-letter-abbott -
MSF open Letter to Abbott from MSF
Open Letter To Abbott Laboratories from Doctors Without Borders/Médecins Sans Frontières (MSF) March 15, 2006 Miles White Chairman and CEO Abbott Laboratories 200 Abbott...
Statements, Speeches, Letters – Last updated 15 March 2006
www.msfaccess.org/content/msf-open-letter-abbott-msf -
MSF's response to Abbott
Open Response to Abbott Laboratories’ Letter to MSF on March 17, 2006 March 23, 2006 Miles White Chairman and CEO Abbott Laboratories 200 Abbott Park Rd. Abbott Park, IL 60064-6189 Sent...
Statements, Speeches, Letters – Last updated 23 March 2006
www.msfaccess.org/content/msfs-response-abbott -
MSF open letter to Abbott
Open Letter to Abbott Laboratories April 5, 2006 Miles White Chairman and CEO Abbott Laboratories 200 Abbott Park Rd. Abbott Park, IL 60064-6189 Sent via facsimile and email Dear...
Statements, Speeches, Letters – Last updated 05 April 2006
www.msfaccess.org/content/msf-open-letter-abbott
